Filing Details
- Accession Number:
- 0001628280-24-050221
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-12-06 16:17:52
- Reporting Period:
- 2024-12-04
- Accepted Time:
- 2024-12-06 16:17:52
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1588978 | Procept Biorobotics Corp | PRCT | Surgical & Medical Instruments & Apparatus (3841) | 260199180 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1599418 | Alaleh Nouri | C/O Procept Biorobotics Corporation 150 Baytech Drive San Jose CA 95134 | Evp, Clo, Corp. Sec. | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2024-12-04 | 11,838 | $7.27 | 64,310 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2024-12-04 | 4,162 | $34.99 | 68,472 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2024-12-04 | 12,092 | $37.02 | 80,564 | No | 4 | M | Direct | |
Common Stock | Disposition | 2024-12-04 | 3,787 | $96.12 | 76,777 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-12-04 | 16,187 | $96.98 | 60,590 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-12-04 | 8,118 | $97.90 | 52,472 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2024-12-04 | 11,838 | $0.00 | 11,838 | $7.27 |
Common Stock | Stock Option (Right to Buy) | Disposition | 2024-12-04 | 4,162 | $0.00 | 4,162 | $34.99 |
Common Stock | Stock Option (Right to Buy) | Disposition | 2024-12-04 | 12,092 | $0.00 | 12,092 | $37.02 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
21,056 | 2031-06-21 | No | 4 | M | Direct | |
2,728 | 2032-03-30 | No | 4 | M | Direct | |
26,094 | 2033-02-15 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on September 3, 2024.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.55 to $96.54, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.56 to $97.54, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $97.58 to $98.24, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
- The Stock option was granted on June 22, 2021 and vested over a four year period.
- The Stock option was granted on March 31, 2022 and vested 1/48th on the anniversary of the vesting commencement date of March 15, 2022, and vesting monthly over a four year period thereafter, subject continued employment or service to the Issuer through the applicable vesting date.
- The Stock option was granted on March 5, 2023 and vests 1/48th of the shares monthly from the vesting commencement date of March 5, 2023 over a four year period thereafter, subject continued employment or service by the Reporting Person to the Issuer through the applicable vesting date.